){kind=logo}
Syrimed is a UK based R&D company dedicated to revolutionising healthcare through the development of innovative and value-added medicines. We specialise in improving generic molecules by formulating advanced proprietary formulations adapted to the clinical needs of patients, to improve their care and ease of administration.
At Syrimed, our focus is on improving patient care in critical conditions such as epilepsy, where exact dosing and dose-tapering are crucial. Our liquid medicines offer precise dosing, and are particularly beneficial for patients unable to swallow tablets, including paediatric patients and those with dysphagia.
Additionally, we have developed tablets in new strengths which provide accurate dosing and easier administration for patients.
Address
4 Bradfield RoadRuislipHA4 ONU
United Kingdom
